Vagus nerve stimulation in treatment-resistant bipolar depression

Clinical Neuropsychiatry

Volumn 6, Issue 6, 2009, Pages 252-258

  Dell'Osso, Bernardo ^a   Dario, Alessandro ^b   Ciabatti, Mariateresa ^a   Camuri, Giulia ^a   Oldani, Lucio ^a   Balossi, Ilaria ^a   Altamura, A Carlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Bipolar disorder (BD); Treatment resistant depression (TRD); Vagus nerve stimulation (VNS)

Indexed keywords

ARIPIPRAZOLE; CLOMIPRAMINE; DULOXETINE; GABAPENTIN; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ANTICONVULSANT ACTIVITY; BIPOLAR DEPRESSION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; EPILEPSY; HUMAN; HYPOMANIA; MAJOR DEPRESSION; NEUROBIOLOGY; REVIEW; VAGUS NERVE STIMULATION;

EID: 74849117183     PISSN: 17244935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. American Psychiatric Association (2000). Practice guidelines for the treatment of patients with major depressive disorder. Am J Psychiatry 157, 1-45.
2. Armitage R, Husain M, Hoffmann R, Rush AJ (2003). The effects of vagus nerve stimulation on sleep EEG in depression: a preliminary report. J Psychosom Res 54, 475-482.
3. Carpenter LL, Moreno FA, Kling MA, et al. (2004). Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine and α-aminobutyric acid concentrations in depressed patients. Biol Psychiatry 56, 418-426.
4. Chae JH, Nahas Z, Lomarev M, et al. (2003). A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res 37, 443-455.
5. Conway CR, Chibnall JT, Fletcher JW, et al. (2002). Three months of vagus nerve stimulation is associated with increased limbic and paralimbic activity (FDG PET) in treatment-resistant depressed subjects. Poster presented at the 57th Annual Scientific Convention of the Society of Biological Psychiatry. Philadelphia, PA, 16-18.
6. Devous MD, Husain M, Harris TS, Rush AJ (2002). Effects of VNS on regional cerebral blood flow in depressed subjects. Poster presented at the 42nd Annual New Clinical Drug Evaluation Unit Meeting. Boca Raton, FL, 10-13.
7. Dorr AE, Debonnel G (2006). Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Ther 318, 2, 890-898.
8. Drevets WC (2001). Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurol 11,2,240-9.
9. Fava M, Davidson KG (1996). Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 19, 179-200.
10. First First MB, Spitzer RL, Gibbon M, et al. (1997). Structured Clinical Inter-view for DSM-IVAxis I (SCID-I) Clinician Version. American Psychiatric Press, Washington DC.
11. Foley JO, DuBois F (1937). Quantitative studies of the vagus nerve in the cat. I. The ratio of sensory motor studies. J Comp Neurol 67, 49-67.
12. Gayetot D, Ansseau M, Triffaux JM (2007). When depression does not end. Resistant depression: recent clinical and therapeutic aspects. Rev Med Liege 62, 103-11.
13. George MS, Rush AJ, Marangell LB, et al. (2005). A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 58,364-373.
14. Guy W (1976). ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. US Department of Health, Education and Welfare, Washington DC, 218-222.
15. Hagen MC, Sheikh JS, Adson D, et al. (2003). Metabolic changes in treatment-resistant depression responsive to VNS therapy. Poster Presented at the 58th Annual Scientific Convention of the Society of Biological Psychiatry, San Francisco, CA, 5-17.
16. Hamilton M (1959). The assessment of anxiety states by rating. Br J Med Psychol 32, 50-55.
17. Husain MM, Stegman D, Trevino K (2005). Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: a case report. Ann Gen Psychiatry 4, 16.
18. Kosel M, Schlaepfer TE (2003). Beyond the treatment of epilepsy: new applications of vagus nerve stimulation in psychiatry. CNS Spectr 8, 7, 515-21.
19. Kraus T, Hosl K, Kiess O (2007). BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transm 114, 11, 1485-1493.
20. Marangell LB, Suppes T, Zboyan HA, et al. (2008). A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder. J Clin Psychiatry 69,2, 183-9.
21. Mayberg HS (2003). Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clin N Am 13, 4, 805-815.
22. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. Br J Psychiatry 134, 382-9.
23. Nahas Z, Marangell LB, Husain MM, et al. (2005). Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 66, 1097-1104.
24. Neuhaus AH, Luborzewski A, Rentzsch J, et al. (2007). P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder. J Affect Disord 100, 123-128.
25. Nierenberg AA, DeCecco LM (2001). Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry 62, 16, 5-9.
26. O'Keane V, Dinan TG, Scott L, Corcoran C (2005). Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression. Biol Psychiatry 58, 963-968.
27. Preskorn SH, Burke M (1992). Somatic therapy for major depressive disorder: selection of an antidepressant. J Clin Psychiatry 53, suppl, 5-18.
28. Rush AJ, George MS, Sackeim HA, et al. (2000). Vagus Nerve Stimulation for treatment resistant depression: a multicenter study. Biol Psychiatry 47, 276-286.
29. Rush AJ, Marangell LB, Sackeim HA, etal. (2005a). Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 58,347-354.
30. Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM et al. (2005b). Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 58, 5, 355-363.
31. Sackeim HA (2001). The definition and meaning of treatment-resistant depression. J Clin Psychiatry 62, suppl, S16, 10-7.
32. Sackeim HA, Rush AJ, George MS, et al. (2001). Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 25, 713-728.
33. Schlaepfer TE, Frick C, Zobel A, Maier W, Heuser I, Bajbouj M et al. (2008). Vagus nerve Stimulation for depression: efficacy and safety in a European study. Psychol Med 4, 1-11.
34. Zobel A, Joe A, Freymann N, et al. (2005). Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach. Psychiatry Res 139,3, 165-79.